Not registered yet? Get a free account.
Sign UpYou're about to leave our website and go to an external link. Are you sure?
Nurexa Pharma Private Limited, is an unlisted private company incorporated on 27 July, 1995. It is classified as a private limited company and is located in , Maharashtra. It's authorized share capital is INR 10.00 lac and the total paid-up capital is INR 2.45 lac.
Nurexa Pharma's operating revenue range is INR 1 cr - 100 cr for the financial year ending on 31 March, 2022. It's EBITDA has increased by 17131.86% over the previous year. At the same time, it's book networth has increased by 18.5%.
Read more
** All rupee values in INR lacs.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
** Delivery timelines are on best-effort basis during working hours. Filings 3-4 hours. Reports 24-48 hours.
* INR 349 for 20+ credits purchase
1 credit = one company dashboard
| State | Type | Address |
|---|
| Designation | Name | DIN/PAN | Tenure |
|---|---|---|---|
| Director | Suneela Ashok Paigankar
Shareholder
|
01104810 | 30 years |
| Director | Sheela Sameer Paigankar
Shareholder
|
01104935 | 29 years |
| Director | Sameer Ashok Paigankar
Shareholder
|
01487210 | 13 years |
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | |
|---|---|---|---|---|---|
| Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Networth | |||||
| Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | |
|---|---|---|---|---|---|
| Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
As per information available, the company has no registered charges.
| Name | Status | Paid up Capital | Common Directors | Address |
|---|---|---|---|---|
| NUTRAGENIX HEALTHCARE PRIVATE LIMITED |
Active
|
10.3 Cr | 2 | Maharashtra |
| HEALTHSKAPE PHARMA PRIVATE LIMITED |
Active
|
1.0 L | 1 | Maharashtra |
| MY HEALTHSKAPE MEDICALS PRIVATE LIMITED |
Active
|
1.8 Cr | 2 | Maharashtra |
| ACUMEDICA CONSULTING PRIVATE LIMITED |
Active
|
2.0 L | 1 | Maharashtra |
| NUTRAGENIX BIOLABS PRIVATE LIMITED |
Strike Off
|
1.0 L | 1 | Maharashtra |
| ACUMEDICA LAB SYSTEMS PRIVATE LIMITED |
Active
|
2.0 Cr | 1 | |
| ADROIT BIOMED LIMITED |
Active
|
44.0 L | 1 | Maharashtra |
| LAVUE PHARMACEUTICALS PRIVATE LIMITED |
Active
|
11.1 Cr | 1 | Maharashtra |
| PHARMA-SERV HEALTHCARE PRIVATE LIMITED |
Active
|
3.5 L | 1 | Maharashtra |
| PHARMA SERV VENTURES PRIVATE LIMITED |
Active
|
10.3 L | 1 | Maharashtra |
| HEMANI INDUSTRIES LIMITED |
Active
|
45.0 Cr | 2 | Maharashtra |
Read more
The incorporation date of NUREXA PHARMA PRIVATE LIMITED is 27 July, 1995
The authorized share capital of NUREXA PHARMA PRIVATE LIMITED is INR ₹ 10.0 L.
The paid-up capital of NUREXA PHARMA PRIVATE LIMITED is INR ₹ 2.5 L.
The registered address of NUREXA PHARMA PRIVATE LIMITED is 3801, 38th Floor, A Wing T 5, Lodha Kiara, Pandurang Budkar Marg, Worli, Lower Parel, Delisle Road, Mumbai, Mumbai, Maharashtra, India, 400013 - 400013
The CIN number of NUREXA PHARMA PRIVATE LIMITED is U24230MH1995PTC091080.